Frangofoto / Shutterstock.com

14 May 2020Plant VarietiesRory O'Neill

EPO clarifies law on plant and animal patentability

The European Patent Office (EPO) has said that plants and animals exclusively obtained by essentially biological processes are not patentable.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Canada takes nursery to court over cherry trees

20 May 2020 Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree.

Biotechnology

EPO president refers plant patentability decision for appeal

2 April 2019 European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

More on this story

Canada takes nursery to court over cherry trees

20 May 2020 Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree.

Biotechnology

EPO president refers plant patentability decision for appeal

2 April 2019 European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

More on this story

Canada takes nursery to court over cherry trees

20 May 2020 Canada’s Department of Agriculture and Agri-Food has accused a Washington-based nursery, a fruit seller, and a fruit grower of infringing a plant patent covering the Staccato type of cherry tree.

Biotechnology

EPO president refers plant patentability decision for appeal

2 April 2019 European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

More features

Startup challenges rival over brain monitoring tech at ITC

UKIPO rejects Boehringer’s SPC for horse inhaler

WilmerHale gains partner with ‘deep expertise’

Bayer, Orion take on Indian generic over $117bn drug

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court